|
|
Volumn 2, Issue 10, 2009, Pages 909-916
|
|
1-Year Survival in a Randomized Trial of Facilitated Reperfusion. Results From the FINESSE (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events) Trial
a
g
HOSPITAL CLÍNIC
(Spain)
|
|
Author keywords
acute myocardial infarction; primary percutaneous coronary intervention; reperfusion therapy
|
|
Indexed keywords
ABCIXIMAB;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PLACEBO;
RETEPLASE;
AGE;
AGED;
ARTICLE;
BLEEDING;
BODY MASS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG DOSE REDUCTION;
FEMALE;
HEALTH CARE UTILIZATION;
HEART CATHETERIZATION;
HEART INFARCTION;
HEART MUSCLE REPERFUSION;
HEART RATE;
HIGH RISK POPULATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
OUTCOME ASSESSMENT;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ST SEGMENT ELEVATION;
SURVIVAL TIME;
SYSTOLIC BLOOD PRESSURE;
AGED;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTIBODIES, MONOCLONAL;
COMBINED MODALITY THERAPY;
DOUBLE-BLIND METHOD;
FEMALE;
FIBRINOLYTIC AGENTS;
HEALTH SERVICES ACCESSIBILITY;
HEMORRHAGE;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MALE;
MYOCARDIAL INFARCTION;
PLATELET AGGREGATION INHIBITORS;
PROPORTIONAL HAZARDS MODELS;
RECOMBINANT PROTEINS;
RISK ASSESSMENT;
RISK FACTORS;
SURVIVAL ANALYSIS;
THROMBOLYTIC THERAPY;
TIME FACTORS;
TISSUE PLASMINOGEN ACTIVATOR;
TREATMENT OUTCOME;
|
|
EID: 70350118832
PISSN: 19368798
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jcin.2009.07.009 Document Type: Article |
|
Times cited : (57)
|
|
References (10)
|
